Moody's
Moody's revenue rose 8.9% to $7.7 billion in fiscal 2025. Its operating margin was 43.4%, up from 40.6% a year earlier. Free cash flow was $2.6 billion, up 2.1%. It paid out $2.3 billion in dividends and buybacks, 90% of free cash flow. The diluted share count fell 1.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 29.2% a year and net income 28.0% a year, as buybacks cut the share count by 8%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Moody's yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
What Moody's says to expect
- Full year 2026: earnings per share
Reaffirmed guidance 2 for full-year 2026, including Diluted EPS range of $16.00 to $16.50 and Adjusted Diluted EPS 1 range of $16.50 to $17.00.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Moody's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Moody's fiscal 2025 free cash flow of $2.6B, net cash of −$4.5B at December 31, 2025 and 180 million diluted shares, from its filings. The scenarios are fitted to Moody's: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 12.2% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9% for a business of moderate risk (Financial Exchanges & Data); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $484.45
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Moody's earnings per share of $16.41 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 26.1×, the middle of Moody's own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $484.45
- Value at this multiple, against the last close
- —
- Moody's P/E at the last close
- 29.5×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| Moody'sMCO | $484.45 | $16.41 | 29.5× |
| NasdaqNDAQ | $104.72 | $3.66 | 28.6× |
| Cboe Global MarketsCBOE | $335.25 | $12.83 | 26.1× |
| CME GroupCME | $308.06 | $12.19 | 25.3× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 1,902 | 1,859 | 2,193 | 2,974 | 2,448 |
| Debt incl. finance leases | 7,413 | 7,389 | 7,001 | 7,428 | 6,994 |
| Net debt (negative means net cash) | 5,511 | 5,530 | 4,808 | 4,454 | 4,546 |
| Net debt to EBITDA | 1.8x | 2.5x | 1.9x | 1.4x | 1.2x |
| Debt to equity | 2.7x | 2.9x | 2.1x | 2.1x | 1.7x |
| Interest coverage | 17.6x | 9.5x | 7.6x | 10.3x | 14.3x |
| Current ratio | 1.6x | 1.7x | 1.7x | 1.5x | 1.7x |
| Quick ratio | 1.6x | 1.7x | 1.7x | 1.5x | 1.7x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Moody's shares on the open market, and 5 insiders sold $13.8 million, $10.0 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 923 | $455.00 | $419,965 | Form 4 |
| Sep 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $501.89 | $736,273 | Form 4 |
| Aug 3, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $484.30 | $710,468 | Form 4 |
| Jul 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $455.49 | $668,204 | Form 4 |
| Jul 1, 2026 | Richard G SteeleSVP - General Counsel | Sold plan | 157 | $455.49 | $71,512 | Form 4 |
| Jun 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $453.67 | $665,534 | Form 4 |
| Jun 1, 2026 | Richard G SteeleSVP - General Counsel | Sold plan | 158 | $453.67 | $71,680 | Form 4 |
| May 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $466.39 | $684,194 | Form 4 |
| May 1, 2026 | Richard G SteeleSVP - General Counsel | Sold plan | 158 | $466.39 | $73,690 | Form 4 |
| Apr 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $437.77 | $642,209 | Form 4 |
| Apr 1, 2026 | Richard G SteeleSVP - General Counsel | Sold plan | 158 | $437.77 | $69,168 | Form 4 |
| Mar 4, 2026 | Michael L WestPresident, Moody's Investors | Sold | 4,250 | $473.72 | $2.0 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Pass |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Pass | Pass | Pass |
| F-score | 9 of 9 | 7 of 9 | 9 of 9 |
| Accruals ratio | −3.8% | −5.2% | −2.8% |
Compare
Put Moody's side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Moody's | FY25 | 8.9% | 43.4% | 33.4% | 31.1% | 1.2x | 9 | |
| Nasdaq | FY25 | 11.7% | 28.2% | 24.1% | 9.5% | 3.4x | 9 | Compare |
| Coinbase | FY25 | 9.4% | 20.0% | 31.9% | 14.5% | −2.4x | 4 | Compare |
| CME Group | FY25 | 6.4% | 64.9% | 64.3% | 11.8% | −0.3x | 7 | Compare |
| Cboe Global Markets | FY25 | 15.1% | 31.1% | 35.7% | 22.8% | −0.5x | 9 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 3,604 | 4,204 | 4,443 | 4,829 | 5,371 | 6,218 | 5,468 | 5,916 | 7,088 | 7,718 |
| Revenue growth | 3.4% | 16.6% | 5.7% | 8.7% | 11.2% | 15.8% | −12.1% | 8.2% | 19.8% | 8.9% |
| Gross profit | — | 2,988 | 3,197 | 3,442 | 3,896 | 4,581 | 3,855 | 4,229 | 5,143 | 5,745 |
| Research and development | 40 | 42 | 51 | — | — | — | — | — | — | — |
| Operating income | 651 | 1,821 | 1,868 | 1,998 | 2,388 | 2,844 | 1,883 | 2,137 | 2,875 | 3,351 |
| Net income | 267 | 1,001 | 1,310 | 1,422 | 1,778 | 2,214 | 1,374 | 1,607 | 2,058 | 2,459 |
| Diluted EPS (US$) | 1.36 | 5.15 | 6.74 | 7.42 | 9.39 | 11.78 | 7.44 | 8.73 | 11.26 | 13.67 |
| Diluted shares (millions) | 195 | 194 | 194 | 192 | 189 | 188 | 185 | 184 | 183 | 180 |
| Cash flow | ||||||||||
| Cash from operations | 1,259 | 755 | 1,461 | 1,675 | 2,146 | 2,005 | 1,474 | 2,151 | 2,838 | 2,901 |
| Capital expenditure | 115 | 91 | 91 | 69 | 103 | 139 | 283 | 271 | 317 | 326 |
| Free cash flow | 1,144 | 664 | 1,370 | 1,606 | 2,043 | 1,866 | 1,191 | 1,880 | 2,521 | 2,575 |
| Dividends paid | 285 | 290 | 337 | 378 | 420 | 463 | 515 | 564 | 620 | 701 |
| Share buybacks | 739 | 200 | 203 | 991 | 503 | 750 | 983 | 490 | 1,292 | 1,607 |
| Acquisitions | 81 | 3,511 | 289 | 162 | 897 | 2,179 | 97 | 3 | 221 | 227 |
| Stock-based compensation | 98 | 123 | 130 | 136 | 154 | 175 | 169 | 193 | 220 | 232 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 2,225 | 1,183 | 1,818 | 1,930 | 2,696 | 1,902 | 1,859 | 2,193 | 2,974 | 2,448 |
| Debt incl. finance leases | 3,363 | 5,540 | — | 5,581 | 6,422 | 7,413 | 7,389 | 7,001 | 7,428 | 6,994 |
| Total assets | 5,327 | 8,594 | 9,526 | 10,265 | 12,409 | 14,680 | 14,349 | 14,622 | 15,505 | 15,830 |
| Total liabilities | 6,355 | 8,709 | 8,870 | 9,428 | 10,646 | 11,764 | 11,660 | 11,146 | 11,778 | 11,625 |
| Shareholders' equity | −1,225 | −328 | 459 | 612 | 1,569 | 2,727 | 2,519 | 3,318 | 3,565 | 4,054 |
| Margins and ratios | ||||||||||
| Gross margin | — | 71.1% | 72.0% | 71.3% | 72.5% | 73.7% | 70.5% | 71.5% | 72.6% | 74.4% |
| Operating margin | 18.1% | 43.3% | 42.0% | 41.4% | 44.5% | 45.7% | 34.4% | 36.1% | 40.6% | 43.4% |
| Net margin | 7.4% | 23.8% | 29.5% | 29.4% | 33.1% | 35.6% | 25.1% | 27.2% | 29.0% | 31.9% |
| Free cash flow margin | 31.7% | 15.8% | 30.8% | 33.3% | 38.0% | 30.0% | 21.8% | 31.8% | 35.6% | 33.4% |
| Return on capital | — | 47.2% | — | — | 38.2% | 32.9% | 17.7% | 21.5% | 26.6% | 31.1% |
| Return on equity | — | — | — | 265.6% | 163.0% | 103.1% | 52.4% | 55.1% | 59.8% | 64.5% |
| Return on assets | 5.1% | 14.4% | 14.5% | 14.4% | 15.7% | 16.4% | 9.5% | 11.1% | 13.7% | 15.7% |
| Net debt to EBITDA | 1.5x | 2.2x | — | 1.7x | 1.4x | 1.8x | 2.5x | 1.9x | 1.4x | 1.2x |